Alerts
PDF
Other content recommended for you
- Novel paraneoplastic mechanism for cerebellar ataxia in Erdheim-Chester disease
- Brainstem and cerebellar involvement in MOG-IgG-associated disorder versus aquaporin-4-IgG and MS
- Imaging in multiple sclerosis and related disorders
- Vemurafenib as first-line therapy in BRAF-V600E-mutant Erdheim-Chester disease with CNS involvement
- Hypothalamic lesions in multiple sclerosis
- Peritoneal or mesenteric tumours revealing histiocytosis
- Erdheim–Chester disease associated with a novel, complex BRAF p.Thr599_Val600delinsArgGlu mutation
- Large-vessel vasculitis possibly induced by BRAF and MEK inhibitors for BRAF V600E positive lung adenocarcinoma
- Efficacy of infliximab in the treatment of Erdheim-Chester disease
- Erdheim-Chester disease: a rare non-Langerhans histiocytosis